ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

Clinicians are encouraged to document the reasons for the use of a particular procedure or test, whether or not it is in conformance with this statement. Clinicians also are advised to take notice of the date this statement was adopted, and to consider other medical and scientific information that b...

Full description

Saved in:
Bibliographic Details
Published in:Genetics in medicine 2023-08, Vol.25 (8), p.100866-100866, Article 100866
Main Authors: Miller, David T., Lee, Kristy, Abul-Husn, Noura S., Amendola, Laura M., Brothers, Kyle, Chung, Wendy K., Gollob, Michael H., Gordon, Adam S., Harrison, Steven M., Hershberger, Ray E., Klein, Teri E., Richards, C. Sue, Stewart, Douglas R., Martin, Christa Lese
Format: Article
Language:English
Subjects:
Base Sequence
Exome - genetics
Exome sequencing
Genetic Testing
Genetics, Medical
Genome sequencing
Genome, Human - genetics
Genomics
Humans
Incidental Findings
Policy
Secondary findings
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinicians are encouraged to document the reasons for the use of a particular procedure or test, whether or not it is in conformance with this statement. Clinicians also are advised to take notice of the date this statement was adopted, and to consider other medical and scientific information that becomes available after that date. It also would be prudent to consider whether intellectual property interests may restrict the performance of certain tests and other procedures. Where individual authors are listed, the views expressed may not reflect those of authors’ employers or affiliated institutions.
ISSN:1098-3600
1530-0366
1530-0366
DOI:10.1016/j.gim.2023.100866